ScoreWhy is Pulike Biological Engineering, Inc. ?
1
The company declared positive results in Mar'25 after very negative results in Dec'24
- OPERATING CASH FLOW(Y) Highest at CNY 428.62 MM
- RAW MATERIAL COST(Y) Fallen by -8.42% (YoY)
- NET PROFIT(9M) Higher at CNY 157.65 MM
2
With ROE of 5.41%, it has a very attractive valuation with a 1.81 Price to Book Value
- Over the past year, while the stock has generated a return of 12.02%, its profits have risen by 9% ; the PEG ratio of the company is 3.7
- At the current price, the company has a high dividend yield of 3
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Pulike Biological Engineering, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Pulike Biological Engineering, Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pulike Biological Engineering, Inc.
0.57%
-0.40
27.31%
China Shanghai Composite
15.17%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.62%
EBIT Growth (5y)
4.93%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.43
Tax Ratio
7.96%
Dividend Payout Ratio
148.09%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.93%
ROE (avg)
8.20%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.81
EV to EBIT
25.47
EV to EBITDA
14.31
EV to Capital Employed
2.11
EV to Sales
3.65
PEG Ratio
3.71
Dividend Yield
2.99%
ROCE (Latest)
8.28%
ROE (Latest)
5.41%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 428.62 MM
RAW MATERIAL COST(Y)
Fallen by -8.42% (YoY
NET PROFIT(9M)
Higher at CNY 157.65 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -29.38 %
-1What is not working for the Company
NET SALES(Q)
Lowest at CNY 263.58 MM
Here's what is working for Pulike Biological Engineering, Inc.
Net Profit
At CNY 157.65 MM has Grown at 42.41%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 428.62 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Lowest at -29.38 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Profit
Higher at CNY 157.65 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Profit (CNY MM)
Raw Material Cost
Fallen by -8.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Pulike Biological Engineering, Inc.
Net Sales
Lowest at CNY 263.58 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
